Care of HIV patients with chronic hepatitis B: updated recommendations from the HIV-Hepatitis B Virus International Panel.
Nearly 10% of the estimated 36 million people having HIV worldwide suffer from chronic hepatitis B virus (HBV) infection. The advent of new antiviral agents against HBV and the recent availability of improved molecular diagnostic tools have revolutioned the management of HIV/HBV coinfected patients. The present study represents an update of the current knowledge about HBV/HIV coinfection and an intent to provide practical advise about how to give the best care to HIV-infected persons with chronic hepatitis B.
Soriano
Vincent
V
Department of Infectious Diseases, Hospital Carlos III, Madrid, Spain. vsoriano@dragones.es
Puoti
Massimo
M
Peters
Marion
M
Benhamou
Yves
Y
Sulkowski
Mark
M
Zoulim
Fabien
F
Mauss
Stefan
S
Rockstroh
Juergen
J
D019380:Anti-HIV Agents / Q000009:adverse effects; D000998:Antiviral Agents / Q000627:therapeutic use*; D024882:Drug Resistance, Viral; D015658:HIV Infections / Q000150:complications*; D017325:Hepatitis B Vaccines / Q000276:immunology; D019694:Hepatitis B, Chronic / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D016031:Liver Transplantation
D019380:Anti-HIV Agents; D000998:Antiviral Agents; D017325:Hepatitis B Vaccines